| Variable | Adjusted estimate (95% CI) |
|---|---|
| Treatment group (postchemotherapy v. exception patient) | 3.00 (0.37 to 8.63) |
| Age at initiation of abiraterone therapy (≥ 70 v. < 70 yr) | -1.00 (-4.93 to 3.47) |
| Bone-targeted therapy (yes v. no) | 1.00 (-1.44 to 3.22) |
| Palliative radiotherapy (yes v. no) | 3.00 (-0.69 to 7.85) |
| Proximity to radiation oncology centre (yes v. no) | 2.00 (-2.29 to 3.41) |
| Rural residence (yes v. no) | 0.00 (-3.28 to 2.60) |
| Diabetes (yes v. no) | 0.00 (-3.88 to 4.46) |
| Dyslipidemia (yes v. no) | 2.00 (0.08 to 6.74) |
| Hypertension (yes v. no) | 2.00 (-0.52 to 3.99) |
| Coronary heart disease (yes v. no) | -1.00 (-3.49 to 1.93) |
| Chronic heart failure (yes v. no) | -2.00 (-4.21 to 5.44) |
| Cerebrovascular disease (yes v. no) | 2.00 (-4.29 to 20.23) |
| Arrhythmia (yes v. no) | 1.00 (-2.56 to 4.69) |
Note: CI = confidence interval.